Cancer mortality according to lipid-lowering drugs and lipoproteins in a general population

References

• Saha SA, Kizhakepunnur LG, Bahekar A, et al. The role of fibrates in the prevention of cardiovascular disease. A pooled meta-analysis of long-term randomized placebo-controlled clinical trials. Am Heart J 2007;154:943-53
   PubMed Web of Science ®Google Scholar
• Dale KM, Coleman CI, Henyan NN, et al. Statins and cancer risk: a meta-analysis. JAMA 2006;295:74-80
   PubMed Web of Science ®Google Scholar
• Browning DR, Martin RM. Statins and risk of cancer: a systematic review and meta-analysis. Int J Cancer 2007;120:833-43
   PubMed Web of Science ®Google Scholar
• Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009;338:b2376
   PubMed Web of Science ®Google Scholar
• WHO. The global burden of disease: 2004 update. Available at: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf [Last accessed 10 July 2010]
   Google Scholar
• Law MR, Thompson SG. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control 1991;2:253-61
   PubMed Web of Science ®Google Scholar
• Jacobs D, Blackburn H, Higgins M, et al. Report of the Conference on Low Blood Cholesterol: mortality associations. Circulation 1992;86:1046-60
   PubMed Web of Science ®Google Scholar
• Eichholzer M, Stähelin HB, Gutzwiller F, et al. Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study 1–3. Am J Clin Nutr 2000;71:569-74
   PubMed Web of Science ®Google Scholar
• Gardette V, Bongard V, Dallongeville J, et al. Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort). Am J Cardiol 2009;103:381-6
   PubMed Web of Science ®Google Scholar
• Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87
   PubMed Web of Science ®Google Scholar
• Marques-Vidal P, Ruidavets JB, Amouyel P, et al. Change in cardiovascular risk factors in France, 1985–1997. Eur J Epidemiol 2004;19:25-32
   PubMed Web of Science ®Google Scholar
• INSERM–IFR69. Mise en oeuvre du décret n_ 98–37 autorisant l’accès aux données relatives au décès des personnes inscrites au Répertoire National d’Identification des Personnes Physiques (RNIPP) dans le cadre des recherches dans le domaine de la santé. Available at: http://ifr69.vjf.inserm.fr/svcd.html [Last accessed 10 July 2010]
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS, et al. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1978;18:499-502
   Google Scholar
• Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509
   Web of Science ®Google Scholar
• Aouba A, Péquignot F, Le Toullec A, et al. Les causes médicales de décès en France en 2004 et leur évolution 1980–2004. Bull Epidemiol Hebdo 2007;35-36:308-14
   Google Scholar
• Danaei G, Vander Hoorn S, Lopez AD, et al. Comparative Risk Assessment Collaborating Group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784-93
   PubMed Web of Science ®Google Scholar
• Lemmens P, Tan ES, Knibbe RA, et al. Measuring quantity and frequency of drinking in a general population survey: a comparison of five indices. J Stud Alcohol 1992;53:476-86
   PubMed Web of Science ®Google Scholar
• Conigrave KM, Davies P, Haber P, et al. Traditional markers of excessive alcohol use. Addiction 2003;98(Suppl 2):31-43
   PubMed Web of Science ®Google Scholar
• Fiorenza AM, Branchi A, Sommariva D, et al. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 2000;30:141-5
   PubMedGoogle Scholar
• Muntoni S, Atzori L, Mereu R, et al. Serum lipoproteins and cancer. Nutr Metab Cardiovasc Dis 2009;19:218-25
   PubMed Web of Science ®Google Scholar
• Kucharska-Newton AM, Rosamond WD, Schroeder JC, et al. HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study. Lung Cancer 2008;61:292-300
   PubMed Web of Science ®Google Scholar
• Jafri H, Alsheikh-Ali AA, Karas RH. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol 2010;55:2846-54
   PubMed Web of Science ®Google Scholar
• Von Eckardstein A, Hersberger M, Rohrer L, et al. Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care 2005;8:147-52
   PubMed Web of Science ®Google Scholar
• Alawi A, Alsheikh-Ali, Thomas A, et al. Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol 2008;52:1141-7
   PubMed Web of Science ®Google Scholar
• Gränsbo K, Melander O, Wallentin L, et al. Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol 2010;55:1362-9
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ 2010;340:c2197
   PubMed Web of Science ®Google Scholar
• Sleijfer S, van der Gaast A, Planting AS, et al. The potential of statins as part of anti-cancer treatment. Eur J Cancer 2005;41:516-22
   PubMed Web of Science ®Google Scholar
• Dormuth CR, Patrick AR, Shrank WH, et al. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009;119:2051-7
   PubMed Web of Science ®Google Scholar
• Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 2007;357:1477-86
   PubMed Web of Science ®Google Scholar
• Tenkanen L, Manttari M, Kovanen PT, et al. Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study. Arch Intern Med 2006;166:743-78
   PubMed Web of Science ®Google Scholar
• Strandberg TE, Pyorala K, Cook TJ, et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 2004;364:771-7
   PubMed Web of Science ®Google Scholar
• Ruidavets JB, Bataille V, Dallongeville J, et al. Alcohol intake and diet in France, the prominent role of lifestyle. Eur Heart J 2004;25:1153-62
   PubMed Web of Science ®Google Scholar